Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France

M. Nasser (Lyon, France), S. Larrieu (Bordeaux, France), L. Boussel (Lyon, France), S. Si-Mohamed (Lyon, France), F. Bazin (Bordeaux, France), S. Marque (Bordeaux, France), J. Massol (Paris, France), D. Revel (Lyon, France), F. Thivolet-Bejui (Lyon, France), L. Chalabreysse (Lyon, France), D. Maucort-Boulch (Lyon, France), E. Hachulla (Lyon, France), S. Jouneau (Lyon, France), V. Cottin (Lyon, France)

Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Nasser (Lyon, France), S. Larrieu (Bordeaux, France), L. Boussel (Lyon, France), S. Si-Mohamed (Lyon, France), F. Bazin (Bordeaux, France), S. Marque (Bordeaux, France), J. Massol (Paris, France), D. Revel (Lyon, France), F. Thivolet-Bejui (Lyon, France), L. Chalabreysse (Lyon, France), D. Maucort-Boulch (Lyon, France), E. Hachulla (Lyon, France), S. Jouneau (Lyon, France), V. Cottin (Lyon, France). Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France. 805

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019

Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014


Identifying chronic thromboembolic pulmonary hypertension (CTEPH) through French national hospital database (PMSI)
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018


Comparison of registries of interstitial lung diseases (ILD) in three European countries
Source: Eur Respir J 2001; 18: Suppl. 33, 440s
Year: 2001

A national registry for childhood interstitial and diffuse lung diseases in the United States.
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018



Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

The burden of chronic obstructive pulmonary disease (COPD) in Taiwan
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013


Healthcare costs and resource use in patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


Prevalence and incidence of interstitial lung diseases (ILDs) in a French multi-ethnic county
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013

Health status & impact of living with idiopathic pulmonary fibrosis (IPF): UK & Ireland Delphi survey
Source: International Congress 2016 – IPF clinical
Year: 2016



Health care system resource utilisation in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

A national French web database for interstitial lung diseases in children
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Healthcare utilization and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014

The outcome of patients with COPD admitted to UK hospitals with an exacerbation. Results from the RCP/BTS national COPD audit
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005


Establishment of the consecutive registration system for pulmonary alveolar proteinosis in Japan: Updated incidence, prevalence and surveillance for intractable cases
Source: International Congress 2016 – Orphan diseases I
Year: 2016

Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada
Source: Eur Respir J 2016; 48: 187-195
Year: 2016



Prevalence of chronic obstructive pulmonary disease (COPD) amongst farmers in rural India
Source: International Congress 2015 – Occupational factors in COPD and bronchitis
Year: 2015


Cirrhotic patients complicated with acute renal and respiratory failure indicated a higher mortality and daily cost than other major diseases – A national health insurance analysis in Taiwan
Source: Annual Congress 2010 - Influence of delivery of care on outcome parameters: therapy is more than medication prescription
Year: 2010